Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × trametinib × 90 days × Clear all

Sponsor

Conditions

Melanoma 12 Carcinoma, Non-Small-Cell Lung 8 Multiple Myeloma 6 Glioma 6 Colorectal Neoplasms 6 Hematologic Neoplasms 4 Neoplasm Metastasis 3 Lymphoma 3 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Neurofibromatosis 1 2 Neoplasms 2 Lung Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Glioblastoma 2 Astrocytoma 2 Uveal Melanoma 1 Thyroid Cancer, Papillary 1 Solid Tumors, KRAS Mutation; SOS1 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Neoplasms by Site 1

Interventions

Rituximab 25 Cyclophosphamide 23 Lenalidomide 20 Prednisone 11 fludarabine 10 Vincristine 10 Doxorubicin 10 obinutuzumab 8 Bendamustine Hydrochloride 8 zanubrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 tazemetostat 6 fludarabine phosphate 6 Biopsy 6 R-CHOP protocol 4 ibrutinib 3 Therapeutics 3 Radiotherapy 3 Exercise 3 Cyclosporine 3 venetoclax 2 tislelizumab 2 tisagenlecleucel 2 pirtobrutinib 2 copanlisib 2 axicabtagene ciloleucel 2 Whole-Body Irradiation 2 Temozolomide 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡